What happened with ITGR today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Integer Holdings Corporation helps large medical-device companies turn their specifications into components, assemblies and finished devices they can bring to market. Customers generally buy directly from Integer, commissioning custom development and manufacturing or purchasing ready-to-distribute device systems. Its brands include Greatbatch Medical and Lake Region Medical.
Cardio and vascular products, including catheters, guidewires and structural-heart devices, generate the largest share of revenue. Devices and components that manage heart rhythm or deliver electrical stimulation to nerves provide most of the rest. Abbott Laboratories, Boston Scientific and Medtronic together supply a large share of sales, making their purchasing decisions important to Integer. Long-term supply agreements do not necessarily guarantee orders: many have no minimum purchase requirements.
Production also depends on critical materials from a limited number of suppliers. Technical requirements and lengthy qualification processes make replacement suppliers difficult to add quickly. Integer must meet FDA and other medical-device rules governing development, manufacturing and sales; noncompliance can restrict operations or prevent products from being sold.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Integer depends on Boston Scientific’s purchases of its medical-device products, which accounted for more than 10% of Integer’s 2025 sales. Boston Scientific sells devices for interventional procedures; its cardiovascular business is worth watching alongside Integer’s growth in heart and vascular device manufacturing.
Medtronic’s purchases of Integer’s medical-device products accounted for more than 10% of Integer’s 2025 sales, making it a major source of revenue for the contract manufacturer. Medtronic serves healthcare systems, clinicians and patients; a substantial loss of its purchasing business would hurt Integer, even though Integer supplies multiple customer subsidiaries and market segments.
Abbott’s purchases of Integer’s medical-device products accounted for more than 10% of Integer’s 2025 sales, so Integer depends on this healthcare-products company for a significant share of revenue. For Integer, the business to watch is Abbott’s device purchasing, rather than its sales of branded generic medicines in emerging markets outside the United States.
Merit Medical competes with Integer for medical-device manufacturers’ spending on cardiovascular components and finished devices. Watch Merit’s business supplying those manufacturers, called OEM, rather than treating all of its cardiovascular and endoscopy sales as direct competition for Integer.
TE Connectivity competes with Integer to sell components used in interventional medical devices to device manufacturers. Its medical-component business is the relevant overlap: TE also sells connectors and sensors into substantial transportation, energy and industrial markets, so its overall results are not a clean guide to Integer’s demand.
Abbott Laboratories earningsABT
Abbott’s report will show whether demand in its medical-device business supports continued purchases from Integer; its other businesses do not directly reveal those orders.
Focus on demand and purchasing signals in Abbott’s medical-device business, not other operations such as medicines as a stand-in for Integer orders. Resilient device demand would support Abbott’s ability to maintain purchases from Integer; weaker demand or reduced purchasing would put pressure on revenue from a customer that accounted for more than 10% of Integer’s 2025 sales.
Integer Holdings Corporation earningsThis company
Integer makes custom components and devices for large medical-device companies, and this report will show whether growth in its cardiovascular business is turning into a higher gross margin.
Read Cardio & Vascular sales growth alongside gross margin. Growth with a steady or higher margin would show that new-product ramps and stronger demand are adding enough production to offset changes in product mix and manufacturing costs. Growth with a lower margin would show that pricing or production costs are eating up more of the increase, weakening the profit quality of that growth.
Medtronic plc earningsMDT
Medtronic’s report will show whether demand for the devices it supplies to health systems, clinicians and patients supports continued purchases from Integer.
Look for demand signals in Medtronic’s device business and whether relevant products support purchasing; its total results are not the same as Integer orders. Firm demand would support continued purchases. Weaker demand or reduced buying would put Integer’s revenue at risk from a customer that represented more than 10% of its 2025 sales, even though purchases span multiple Medtronic subsidiaries and markets.
